Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9027)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Nov 15, 2020 (publication date) through Apr 15, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Sheng QJ, Tian WY, Dou XG, Zhang C, Li YW, Han C, Fan YX, Lai PP, Ding Y. Programmed death 1, ligand 1 and 2 correlated genes and their association with mutation, immune infiltration and clinical outcomes of hepatocellular carcinoma. World J Gastrointest Oncol 2020; 12(11): 1255-1271 [PMID: 33250959 DOI: 10.4251/wjgo.v12.i11.1255] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v12/i11/1255.htm |
| Number | Citing Articles |
| 1 |
Yanjie Ruan, Jiyu Wang, Qiuye Zhang, Huiping Wang, Cong Li, Xuanxuan Xu, Zhimin Zhai. Clinical implications of aberrant PD-1 expression for acute leukemia prognosis. European Journal of Medical Research 2023; 28(1) doi: 10.1186/s40001-023-01352-8
|
| 2 |
Md Rakibul Alam, Md Mizanur Rahman, Zhiguo Li. The link between intracellular calcium signaling and exosomal PD-L1 in cancer progression and immunotherapy. Genes & Diseases 2024; 11(1): 321 doi: 10.1016/j.gendis.2023.01.026
|
| 3 |
Tiefeng Jin, Wei Wang, Luqi Ge, Xiang Li, Minghua Ge. The expression of two immunosuppressive SIGLEC family molecules in papillary thyroid cancer and their effect on prognosis. Endocrine 2023; 82(3): 590 doi: 10.1007/s12020-023-03452-1
|
| 4 |
Jyoti Singh, Abha Meena, Suaib Luqman. New frontiers in the design and discovery of therapeutics that target calcium ion signaling: a novel approach in the fight against cancer. Expert Opinion on Drug Discovery 2023; 18(12): 1379 doi: 10.1080/17460441.2023.2251887
|
| 5 |
Jian Liu, Yiwei Li, Wenke Shen, Ting Wang, Yuanyuan Liu, Junbai Ma, Xiaoxu Zhang, Ting Li, Wenyan Tian, Xiaolong Ma, Lina Zhang, Ke Li, Ming Li, Xiaoxia Zhang, Qing Liu, Hao Wang. Dietary supplementation of α-linolenic acid-rich flaxseed oil enhances anti-PD-1 protection against orthotopic hepatocellular carcinoma by reshaping gut homeostasis and improving anti-tumor immunity via gut-liver axis in mice. Journal of Functional Foods 2024; 116: 106157 doi: 10.1016/j.jff.2024.106157
|
| 6 |
Ugo Testa, Elvira Pelosi, Germana Castelli. Clinical value of identifying genes that inhibit hepatocellular carcinomas. Expert Review of Molecular Diagnostics 2022; 22(11): 1009 doi: 10.1080/14737159.2022.2154658
|
| 7 |
Lei Guo, Hongbo Li, Tianli Fan, Yanli Ma, Lili Wang. Synergistic efficacy of curcumin and anti-programmed cell death-1 in hepatocellular carcinoma. Life Sciences 2021; 279: 119359 doi: 10.1016/j.lfs.2021.119359
|
| 8 |
Bojana Gutic, Tatjana Bozanovic, Aljosa Mandic, Stefan Dugalic, Jovana Todorovic, Dejana Stanisavljevic, Miroslava Gojnic Dugalic, Demet Sengul, Dzenana A. Detanac, Ilker Sengul, Dzemail Detanac, José Maria Soares. Programmed cell death-1 and its ligands: Current knowledge and possibilities in immunotherapy. Clinics 2023; 78: 100177 doi: 10.1016/j.clinsp.2023.100177
|
| 9 |
Gao-Lei Liu, Hao Luo, Dan-Dan Liang, Li Zhong, Nan Dai, Wei-Hua Lan. Comprehensive Analysis of Prognostic Alternative Splicing Signatures in Tumor Immune Infiltration in Bladder Cancer. Recent Patents on Anti-Cancer Drug Discovery 2025; 20(2): 185 doi: 10.2174/0115748928329276241020184935
|
| 10 |
Mei-Ying Gu, Wan-Long Ma, Zi-min Ma, Li-Na Ma, Xiang-Chun Ding. Expression of PSMD2 gene in hepatocellular carcinoma and its correlation with immune checkpoints and prognosis. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-94504-1
|
| 11 |
Yan Lv, Kai Gai, Xia Ding, Weihua Sun. Soluble forms of PD-1 and sPD-L1/2 in serum and urine of patients with head and neck cancer and their clinical significance. Biotechnology and Genetic Engineering Reviews 2024; 40(3): 2234 doi: 10.1080/02648725.2023.2199237
|
| 12 |
Yun-Yun Tao, Yue Shi, Xue-Qin Gong, Li Li, Zu-Mao Li, Lin Yang, Xiao-Ming Zhang. Radiomic Analysis Based on Magnetic Resonance Imaging for Predicting PD-L2 Expression in Hepatocellular Carcinoma. Cancers 2023; 15(2): 365 doi: 10.3390/cancers15020365
|
| 13 |
Gabriel F. Hess, Caner Ercan, Alexander Wilhelm, Jasmin Zeindler, Mairene Coto-Llerena, Silvio Däster, Simone Muenst, Jürg Vosbeck, Luca Di Tommaso, Martin Bolli, Luigi M. Terracciano, Otto Kollmar, Salvatore Piscuoglio, Savas D. Soysal. Immuno-Activated, Highly Expressing PD-1 Phenotype in Hepatocellular Carcinoma Is Associated with a Lower Recurrence Rate. Pathobiology 2025; : 1 doi: 10.1159/000543933
|
| 14 |
Ling Wu, Weidong Lian, Liang Zhao. Calcium signaling in cancer progression and therapy. The FEBS Journal 2021; 288(21): 6187 doi: 10.1111/febs.16133
|
| 15 |
Mengqing Si, Xianwei Cao, B. D. Parameshachari. [Retracted] Considering Computational Mathematics IGHG3 as Malignant Melanoma Is Associated with Immune Infiltration of Malignant Melanoma. BioMed Research International 2022; 2022(1) doi: 10.1155/2022/4168937
|